Target intelligence / Profile preview

RNA, U6 small nuclear 877, pseudogene (RNU6-877P)

Target: RNU6-877P
Molecular classification: Other (pseudogene); not a receptor, enzyme, transporter, ion channel, transcription factor, or histone modifier

Overview

RNU6-877P is a pseudogene derived from the U6 small nuclear RNA (U6 snRNA) gene family, annotated in the human genome (NCBI Gene: 106480617, Ensembl: ENSG00000206595). Unlike the functional U6 snRNA, which is a key component of the spliceosome and mediates excision of introns from pre-mRNAs, pseudogenes such as RNU6-877P generally lack protein-coding capacity and do not perform the core biological functions of their parent gene. Most pseudogenes are non-functional genomic relics; however, emerging evidence suggests some pseudogenes may exert epigenetic or post-transcriptional regulatory roles, including acting as competing endogenous RNAs (ceRNAs), generating siRNAs, or modulating gene expression via interaction with RNA-binding proteins. There is no current evidence to suggest that RNU6-877P itself plays any specific regulatory, physiological, or pathological role.

Other names: RNU6-877PRNA, U6 small nuclear 877, pseudogene

Mechanism of action

None; as above.

Biological functions

None established for the pseudogene. The parental U6 snRNA is involved in pre-mRNA splicing within the spliceosome, but pseudogenes generally lack such functions, except for occasional regulatory/ncRNA roles described below

Disease associations

None directly established for RNU6-877P. General pseudogene literature describes potential roles for pseudogenes in cancer and other diseases, often through regulation of their parental genes or competing for regulatory molecules, but specific data for RNU6-877P are unavailable

Safety considerations

None applicable; not a druggable or actionable molecular entity.

Interacting drugs

None reported; as a pseudogene, RNU6-877P is not a molecular target for any approved or experimental drugs.

Biomarkers

None reported for RNU6-877P itself. Pseudogenes can sometimes serve as disease biomarkers, but there is no published evidence for this specific pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 877, pseudogene (RNU6-877P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 877, pseudogene (RNU6-877P).

Explore the full profile